Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Caribou Biosciences Inc
(NQ:
CRBU
)
3.050
-0.060 (-1.93%)
Streaming Delayed Price
Updated: 10:45 AM EDT, May 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Caribou Biosciences Inc
< Previous
1
2
3
4
5
6
7
Next >
Caribou Biosciences Reports Positive Clinical Data from Dose Escalation of CB-010 ANTLER Phase 1 Trial in r/r B-NHL
July 13, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
2 Magnificient Growth Stocks to Buy in July
July 13, 2023
These two growth stocks might be incredibly undervalued right now.
Via
The Motley Fool
3 Biotech Stocks to Buy for Long-Term Gains
July 13, 2023
The biotech sector is one of the most volatile sectors, but here are three biotech stocks that offer opportunities for patient biotech stock investors.
Via
MarketBeat
Topics
ETFs
Economy
Exposures
Interest Rates
12 Health Care Stocks Moving In Friday's Intraday Session
July 07, 2023
Via
Benzinga
Caribou Biosciences: Q1 Earnings Insights
May 09, 2023
Via
Benzinga
Pfizer Just Invested $25 million In This Biotech
July 07, 2023
Pfizer's investment propels Caribou Biosciences' stock and fuels optimism for its lead candidates: CB-010 and CB-011, both currently in phase 1 trials.
Via
MarketBeat
Benzinga's Stock Whisper Index: 5 Tickers Investors Secretly Monitor But Don't Talk About... Yet
July 07, 2023
Investors are on the hunt for undervalued, under followed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. For some, this may be...
Via
Benzinga
Nasdaq Drops Over 100 Points; Genius Sports Shares Spike Higher
July 06, 2023
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping over 100 points on Thursday. The Dow traded down 1.09% to 33,913.56 while the NASDAQ fell 0.96% to 13,659.77. The...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 06, 2023
Via
Benzinga
Crude Oil Moves Lower; ISM Services PMI Surges In June
July 06, 2023
U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 450 points on Thursday. The Dow traded down 1.38% to 33,814.23 while the NASDAQ fell 1.37% to 13,602.19. The S&P 500,...
Via
Benzinga
Why Shares of Caribou Biosciences Are Skyrocketing Today
July 06, 2023
The company's shares spiked after Pfizer bought $25 million of Caribou stock.
Via
The Motley Fool
The $25 Million Reason Caribou Biosciences (CRBU) Stock Is Soaring Today
July 06, 2023
Caribou Biosciences (CRBU) stock is taking off on Thursday after the gene-editing company announced an investment from Pfizer (PFE).
Via
InvestorPlace
Pfizer (NYSE: PFE) Invests $25 Million in Caribou Biosciences (NASDAQ: CRBU)
July 06, 2023
On July 6, 2023, Caribou Biosciences, Inc., a significant player in the field of CRISPR genome-editing biopharmaceuticals, announced a $25
Via
Spotlight Growth
Why Caribou Biosciences Shares Are Trading Higher By Around 58%? Here Are Other Stocks Moving In Thursday's Session
July 06, 2023
Gainers Caribou Biosciences, Inc. (NASDAQ: CRBU) shares jumped 58.1% to $6.45 after the company announced a $25 million equity investment from Pfizer.
Via
Benzinga
Pfizer Is Driving Caribou Biosciences Stock Higher Today: What's Going On?
July 06, 2023
Caribou Biosciences, Inc. (NASDAQ: CRBU) shares are racing higher on Thursday after the company announced a $25 million equity investment from
Via
Benzinga
Dow Tumbles Over 300 Points; US Jobless Claims Increase More Than Projected
July 06, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping over 300 points on Thursday. Following the market opening Thursday, the Dow traded down 0.96% to 33,958.13 while the NASDAQ fell 1.06%...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 06, 2023
Via
Benzinga
Caribou Biosciences Announces $25 Million Equity Investment from Pfizer
July 06, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating Caribou Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
June 21, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Caribou Biosciences to Participate in Upcoming Investor Conferences
May 31, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Caribou Biosciences, Inc. (NASDAQ:CRBU) Long Term Investor Alert: Investigation over Possible Wrongdoing
May 22, 2023
San Diego, CA -- (SBWIRE) -- 05/22/2023 -- Certain directors of Caribou Biosciences, Inc. are under investigation concerning potential breaches of fiduciary duties.
Via
SBWire
Caribou Biosciences Reports First Quarter 2023 Financial Results and Provides Business Update
May 09, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Caribou Biosciences Announces Appointment of Stephen J. Schuster, MD, to its Scientific Advisory Board
May 08, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Caribou Biosciences to Participate in Upcoming Investor Conferences
May 01, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Caribou Biosciences Presents New Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the 2023 AACR Annual Meeting
April 17, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Caribou Biosciences, Inc. (CRBU) Investors of Class Action and to Actively Participate
April 10, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
CARIBOU DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Caribou Biosciences, Inc. and Encourages Investors to Contact the Firm
April 07, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
CRBU FINAL DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important April 11 Deadline in Securities Class Action - CRBU
April 07, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
NASDAQ:CRBU Investor Alert: Deadline on April 11, 2023 in Lawsuit Against Caribou Biosciences, Inc. Coming Up
April 05, 2023
San Diego, CA -- (SBWIRE) -- 04/05/2023 -- The Shareholders Foundation announced that a deadline is coming up on April 11, 2023 in the lawsuit filed for certain investors of Caribou Biosciences, Inc....
Via
SBWire
Caribou Biosciences Announces FDA Granted Fast Track Designation to CB-011, an Allogeneic CAR-T Cell Therapy for Relapsed or Refractory Multiple Myeloma
April 04, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.